Loading clinical trials...
Loading clinical trials...
This study aims at exploring patients' ability to monitor their own memory performance depending on their primary deficit and the type of memory involved in the criterion task. The goal is to evaluate if semantic dementia (SD) and Alzheimer's disease (AD) differently affect patients' awareness of their memory abilities.
Patients who will give their informed non-opposition will be included. Participants will undergo 6 metacognitive tasks in which they will be tested on newly learnt information (i.e., episodic memory) or prior knowledge (i.e., semantic memory) and asked to evaluate their performance either prior or after the test. Correlation between their evaluation and their actual performance will be measured. Performance and correlations will be compared across groups.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
CHU Angers
Angers, France
CHU Bordeaux
Bordeaux, France
Hôpital Neurologique de Lyon
Bron, France
Hôpitaux Civils Colmar
Colmar, France
Chu Grenoble Alpes
Grenoble, France
CHU Rennes
Rennes, France
CHU Vaudois
Lausanne, Switzerland
Start Date
October 16, 2020
Primary Completion Date
April 27, 2022
Completion Date
April 27, 2022
Last Updated
August 7, 2023
40
ACTUAL participants
Metacognition tests
OTHER
Lead Sponsor
University Hospital, Grenoble
NCT06716502
NCT00090662
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06290258